SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-075314
Filing Date
2019-12-23
Accepted
2019-12-23 08:15:19
Documents
3
Period of Report
2019-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1927282d1_8k.htm 8-K 24182
2 EXHIBIT 99.1 tm1927282d1_ex99-1.htm EX-99.1 11276
3 GRAPHIC tm1927282d1_ex99-1img001.jpg GRAPHIC 4097
  Complete submission text file 0001104659-19-075314.txt   42369
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38586 | Film No.: 191303479
SIC: 2836 Biological Products, (No Diagnostic Substances)